FBTTX vs. FHCCX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class M (FBTTX) and Fidelity Advisor Health Care Fund Class C (FHCCX).
FBTTX is managed by Fidelity. It was launched on Dec 27, 2000. FHCCX is managed by Fidelity. It was launched on Nov 3, 1997.
Performance
FBTTX vs. FHCCX - Performance Comparison
Loading graphics...
FBTTX vs. FHCCX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.18% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
FHCCX Fidelity Advisor Health Care Fund Class C | -6.24% | -5.49% | 3.20% | 3.02% | -13.72% | 10.43% | 20.15% | 26.96% | 6.37% | 23.12% |
Returns By Period
In the year-to-date period, FBTTX achieves a 2.18% return, which is significantly higher than FHCCX's -6.24% return. Over the past 10 years, FBTTX has outperformed FHCCX with an annualized return of 11.54%, while FHCCX has yielded a comparatively lower 5.98% annualized return.
FBTTX
- 1D
- 5.09%
- 1M
- -0.77%
- YTD
- 2.18%
- 6M
- 15.39%
- 1Y
- 55.03%
- 3Y*
- 20.14%
- 5Y*
- 8.63%
- 10Y*
- 11.54%
FHCCX
- 1D
- 3.94%
- 1M
- -5.40%
- YTD
- -6.24%
- 6M
- -14.50%
- 1Y
- -9.01%
- 3Y*
- -2.07%
- 5Y*
- -2.42%
- 10Y*
- 5.98%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBTTX vs. FHCCX - Expense Ratio Comparison
FBTTX has a 1.28% expense ratio, which is lower than FHCCX's 1.72% expense ratio.
Return for Risk
FBTTX vs. FHCCX — Risk / Return Rank
FBTTX
FHCCX
FBTTX vs. FHCCX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class M (FBTTX) and Fidelity Advisor Health Care Fund Class C (FHCCX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBTTX | FHCCX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.92 | -0.40 | +2.33 |
Sortino ratioReturn per unit of downside risk | 2.52 | -0.34 | +2.86 |
Omega ratioGain probability vs. loss probability | 1.32 | 0.94 | +0.38 |
Calmar ratioReturn relative to maximum drawdown | 3.13 | -0.43 | +3.56 |
Martin ratioReturn relative to average drawdown | 12.48 | -1.05 | +13.53 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBTTX | FHCCX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.92 | -0.40 | +2.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.37 | -0.13 | +0.50 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.31 | +0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.46 | -0.16 |
Correlation
The correlation between FBTTX and FHCCX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FBTTX vs. FHCCX - Dividend Comparison
FBTTX's dividend yield for the trailing twelve months is around 1.50%, while FHCCX has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
FHCCX Fidelity Advisor Health Care Fund Class C | 0.00% | 0.00% | 17.59% | 0.00% | 0.00% | 8.32% | 6.85% | 0.41% | 6.43% | 0.00% | 0.00% | 7.84% |
Drawdowns
FBTTX vs. FHCCX - Drawdown Comparison
The maximum FBTTX drawdown since its inception was -63.75%, which is greater than FHCCX's maximum drawdown of -45.28%. Use the drawdown chart below to compare losses from any high point for FBTTX and FHCCX.
Loading graphics...
Drawdown Indicators
| FBTTX | FHCCX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.75% | -45.28% | -18.47% |
Max Drawdown (1Y)Largest decline over 1 year | -13.58% | -27.25% | +13.67% |
Max Drawdown (5Y)Largest decline over 5 years | -36.64% | -29.67% | -6.97% |
Max Drawdown (10Y)Largest decline over 10 years | -39.04% | -29.67% | -9.37% |
Current DrawdownCurrent decline from peak | -2.61% | -24.39% | +21.78% |
Average DrawdownAverage peak-to-trough decline | -21.95% | -10.12% | -11.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.72% | 11.03% | -7.31% |
Volatility
FBTTX vs. FHCCX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a higher volatility of 9.37% compared to Fidelity Advisor Health Care Fund Class C (FHCCX) at 7.07%. This indicates that FBTTX's price experiences larger fluctuations and is considered to be riskier than FHCCX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBTTX | FHCCX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.37% | 7.07% | +2.30% |
Volatility (6M)Calculated over the trailing 6-month period | 17.02% | 22.46% | -5.44% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.99% | 25.67% | +0.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.31% | 19.41% | +3.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.58% | 19.58% | +5.00% |